The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Just to add some balance. A virus usually mutates to becomes less deadly. It can’t pass itself on of it kills its host. We already have 4 other Covid based viruses circulating the globe and yet they don’t make the news because they are not sensational enough. Cases will no doubt increase but deaths and severe cases will drop....... thank goodness. Another indicator, is that to date, no child has died. So 80,000 plus cases globally and zero child fatalities. The virus is selective (at the moment) and unfortunately prays on the weak. Our thoughts should be with those impacted by this and less on opportunistic money making.
The majority of people going long (my opinion only) are expecting to see £4.50 again. Dilution would be the major threat. I originally thought by end of March we may see £4 but would be happy to wait a little / a lot longer, as this appears to be a much slower burn.
He appears positive about results day anyway . He made sure to mention that in his official statement. Going on the limited wording and tone of his update; dilution less likely on the cards . Plus ....cash flow ok due to customer number increase over the last period (and future projected via new stores) ....... inevitable cost cutting plans but technology based Vs mass hacking into Ops staff which would be a slower transformation. If they can prove the high street model is working and the profit dip was a one off then they can spin the story well enough to see this steady in the 200’s
Just loaded up at 196. That will be my last ever top up. Sights still firmly on 400p, and for the first time, I think the short squeeze will have to play a part in hitting that. Positive FCA news and average to good results will be required. Leadership team is just noise.
Each to their own but it was always going to be around 190 - 230 before results, so why sell now when you had a good 6 weeks run up to this point to get out. Yes is May drift lower, but I can’t see a huge fundamental change since December and I personally think the risk reward is where is always has been since it hit the 170 mark and if anything, it’s slightly better since the election result.
Having started to buy in sub 450 all the way down to 170 ...... this has felt like the most dismal week yet, despite monthly gains. A RNS at 17:00 would be nice but it’s all about results day now. Can see a nice pop to 260 + if all goes well. If they provide results AND something more spicy like a strategic update involving a JV or buyout then who knows where it could end up. Wake me up in a couple of weeks
Proof the “non high-street” space is saturated. N26 peaked at 200k customers. Blamed Brexit ...... cheap excuse.
https://www.google.co.uk/amp/s/www.bbc.co.uk/news/amp/business-51463632
Dogger - if you are at the stage where you have accepted you might sell it all......then at least wait another week. It may go up or down a few % but there is a higher chance it will rocket up than rocket down.
Dogger you have the advice Novek gave you, and as we all know, he is the only one qualified on this board to give advice. He said you would be best off trading the peaks. Presumably selling after a surge and buying back in lower in the retrace. Sounds hugely risky but hey he is the “expert” .